Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 2.305

+9.2%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (511)	11/11/1998 8:25:00 PM
From: Dan Spillane	Read Replies (2) of 2539

No wonder Merck's stock is going down. They ain't as ready as they led people to believe. And here I thought the only advantage of the Monsanto/Searle drug is that it doesn't have the edema side-effect like the Merck drug does. Apparently Searle also has a bigger lead than we thought. (From the story) Merck has done studies based on endoscopic examinations, but said its results weren't ready by the conference's publication deadline. ''That information is what everyone is seeking at this point, but we just don't have it,'' said Kyra Lindemann, a Merck spokeswoman.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next